Ceftazidime hydrate
SIGMA/A6987
Synonym: 1-
CAS Number: 120618-65-7
Empirical Formula (Hill Notation): C22H22N6O7S2 · xH2O
Molecular Weight: 546.58 (anhydrous basis)
MDL Number: MFCD00153936
Linear Formula: C22H22N6O7S2 · xH2O
Product Type: Chemical
| antibiotic activity spectrum | Gram-negative bacteria |
| Gram-positive bacteria | |
| assay | 95.0-102.0% anhydrous basis |
| description | does not contain sodium carbonate |
| form | powder or crystals |
| InChI | 1S/C22H22N6O7S2.5H2O/c1-2 |
| InChI key | NMVPEQXCMGEDNH-TZVUEUGBSA |
| mode of action | cell wall synthesis | interferes |
| Quality Level | 200 ![]() |
| SMILES string | [H]O[H].[H]O[H].[H]O[H].[ |
| storage temp. | 2-8°C |
| Application: | Ceftazidime hydrate is used to study the effect of expression, binding and inhibition of penicillin-binding proteins especially PBP3 on bacterial cell wall mucopeptide synthesis. It is also used in bacterial susceptibility studies and to select mutant colonies of interest. |
| Application: | Used to study the effect of expression, binding and inhibition of penicillin-binding proteins especially PBP3 on bacterial cell wall mucopeptide synthesis. |
| Biochem/physiol Actions: | Cephalosporins, such as ceftazidime , disrupt the synthesis of the peptidoglycan layer of bacterial cell walls. |
| General description: | Broad spectrum antibiotic; third generation cephalosporin |
| Other Notes: | Keep container tightly closed in a dry and well-ventilated place. |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H317 - H334 |
| Precautionary statements | P261 - P280 - P342 + P311 |
| Hazard Codes | Xn |
| Risk Statements | 42/43 |
| Safety Statements | 22-36/37-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | 95.0-102.0% anhydrous basis |
| Storage Temp. | 2-8°C |
| UNSPSC | 51284108 |


